Hong Kong
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
55.15%
|
Dec. 31, 2023 | USD 0.32 | -0.02% |
|
Hong Kong |
|
2 |
37.47%
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
3 |
33.85%
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
4 |
28.08%
|
Dec. 31, 2023 | USD 0.43 | -0.61% |
|
Hong Kong |
|
5 |
26.87%
|
March 31, 2024 | USD 0.24 | -1.06% |
|
Hong Kong |
|
6 |
25.36%
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
7 |
23.94%
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
8 |
23.63%
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
9 |
22.70%
|
March 31, 2024 | USD 0.16 | -3.92% |
|
Hong Kong |
|
10 |
22.08%
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
11 |
7.88%
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
12 |
7.78%
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
13 |
4.49%
|
Dec. 31, 2023 | USD 0.67 | 1.15% |
|
Hong Kong |
|
14 |
3.86%
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
15 |
3.42%
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
16 |
3.23%
|
March 31, 2024 | USD 0.46 | 4.31% |
|
Hong Kong |
|
17 |
2.19%
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
18 |
-1.95%
|
Dec. 31, 2023 | USD 0.21 | -5.19% |
|
Hong Kong |
|
19 |
-49.12%
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
|
20 |
-238.73%
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
21 |
-16,818.68%
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
22 |
-19,432.24%
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
The Pharmaceuticals company in Hong Kong with the highest Operating Income Margin is Pak Fah Yeow International Limited (HKSE: 0239.HK) at 55.15%.
The Pharmaceuticals company in Hong Kong with the lowest Operating Income Margin is Sirnaomics Ltd. (HKSE: 2257.HK) at -19,432.24%.
The top 10 Pharmaceuticals companies in Hong Kong by Operating Income Margin are Pak Fah Yeow International Limited, Dawnrays Pharmaceutical (Holdings) Limited, China Medical System Holdings Limited, Tycoon Group Holdings Limited, JBM (Healthcare) Limited, SSY Group Limited, The United Laboratories International Holdings Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Jacobson Pharma Corporation Limited and Sino Biopharmaceutical Limited.
The bottom 10 Pharmaceuticals companies in Hong Kong by Operating Income Margin are Sirnaomics Ltd., SinoMab BioScience Limited, Prenetics Global Limited, BeiGene, Ltd., Chia Tai Enterprises International Limited, HUTCHMED (China) Limited, Alibaba Health Information Technology Limited, Lee's Pharmaceutical Holdings Limited, Guangdong Hybribio Biotech Co.,Ltd. and China Resources Pharmaceutical Group Limited.